A Realworld Study of Acute Respiratory Distress Syndrome in China

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-08-31

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ARDS is a critical respiratory disease caused by endogenous and exogenous factors. The mortality of ARDS varies from 30 to 70%. In 2012, a new international diagnostic criterion has been put forward. Yet, its feasibility, reliability and validity need to be tested. Meanwhile, the correlation of different severity and prognosis remains unclear. As so far, the epidemiological information about ARDS in China is lacking.

Investigators plan to conduct a multi-center observational study（real-life study） to investigate the risk factors, morbidity, management and prognosis of ARDS in China, in order to facilitate standardization of diagnosis and management of ARDS and provide basic data and idea for further clinical intervention studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ALI/ARDS Clinical Sub-phenotyping Study

NCT06123962

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

RECRUITING

Epidemiological Characteristics and Prediction System of Acute Respiratory Distress Syndrome

NCT06069466

Acute Respiratory Distress Syndrome

UNKNOWN

Exploration of Diagnosis and Treatment Strategies and Prognostic Prediction Models for Acute Respiratory Distress Syndrome Based on Radiographic Evaluations Assessed by Artificial Intelligence

NCT07328997

ARDS (Acute Respiratory Distress Syndrome) AI (Artificial Intelligence)

COMPLETED

The Mechanism of lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome Through miR-27b Regulated Nrf2 Pathway

NCT04937855

Acute Respiratory Distress Syndrome Inflammation

UNKNOWN

Stratification of the Acute Respiratory Distress Syndrome - A Second Phase Study

NCT02836444

Acute Respiratory Distress Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years of age; hospitalized patients with main diagnosis as ARDS.

Exclusion Criteria

* \<18 years of age
* Patients or their families refused to participate in the study
* Patients diagnosed as COPD, pulmonary fibrosis or bronchiectasis

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No